CENTENNIAL, Colo., Aug. 9, 2011 /PRNewswire/ — AlloSource, a
leading developer, processor and distributor of bone and
soft-tissue allografts for use in surgical procedures around the
world, today announced two new key affiliations with the Alliance
for Regenerative Medicine (ARM) and the Medical Device
Manufacturers Association (MDMA). AlloSource pursued
membership with both organizations in order to support medical
device and regenerative medicine grassroots efforts with policy
makers.
ARM is a nonprofit whose mission is to educate key policy makers
about the potential of regenerative medicine and to advocate for
favorable public policies to facilitate advances in the field. MDMA
is a national trade association providing educational and advocacy
assistance to innovative and entrepreneurial medical technology
companies. Both organizations have already made progress in
growing the knowledge base of Capitol Hill influencers on the
current industry issues that affect their member organizations.
“AlloSource honors the gift of life from donors and their
families by safely and respectfully processing donated tissue, and
because of this we are dedicated to expanding the medical
possibilities of tissue transplantation,” Thomas Cycyota,
AlloSource President and CEO. “We look forward to working
with the Alliance for Regenerative Medicine and the Medical Device
Manufacturers Association to educate regulators on the ways
regenerative medicine and medical devices using donated tissue do
and will continue to greatly improve the quality of life for
millions of patients in need.”
AlloSource recently expanded its product offerings with the
addition of AlloStem® Stem Cell Bone Growth Substitute, which
pioneers the use of mesenchymal stem cells derived from donor
adipose tissue for orthopedic applications, helping to stimulate
natural bone formation. Through the osteobiologics products they
produce, the company has facilitated approximat
‘/>”/>